Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04428333 |
|---|---|
| Brief Title: | Study of GSK3359609 With Pembrolizumab and 5-fluorouracil (5-FU)-Platinum Chemotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (INDUCE-4) |
| First Submitted : | June 9, 2020 |
| First Submitted that Met QC Criteria : | June 9, 2020 |
| First Posted : | June 11, 2020 |
| Last Update Submitted that Met QC Criteria : | January 12, 2021 |
| Last Update Posted : | January 14, 2021 |